Phibro Animal Health | PAHC - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Align Technology USD 178.05M 46.66M 2026-03
ANI Pharmaceuticals USD 38.71M 9.58M 2026-03
Aurora Cannabis CAD -35.79M 19.88M 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Canopy Growth CAD -12.66M 1.64M 2025-12
Corcept Therapeutics USD -49.6M 54.09M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Henry Schein USD 182M 4M 2026-03
Idexx Laboratories USD 362.59M 46.98M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Merck USD -1.88B 8.12B 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Pacira USD 4.62M 1.43M 2026-03
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 75.49M 7M 2026-03
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
Zoetis USD 865M 30M 2026-03